Pilot Study of Bone Biopsy and Aspirate in Women With Metastatic Breast Cancer
Terminated
- Conditions
- Metastatic Breast Cancer
- Registration Number
- NCT01975597
- Lead Sponsor
- University of Michigan Rogel Cancer Center
- Brief Summary
This is a feasibility study to demonstrate the team's ability to collect bone marrow aspirates and biopsies for research purposes from women with metastatic breast cancer.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 8
Inclusion Criteria
- Patients with metastatic breast cancer (any site) age 21 or older
- Patients willing and able to provide informed consent & perform study procedures
- Patients may enroll with recently (with 2 months) progressive tumor burden
- Performance status of 0,1 or 2
Exclusion Criteria
- Patients unable or unwilling to provide informed consent and or perform study procedures
- Patients with active, uncontrolled coagulopathy
- Patients on treatment dose anticoagulation or an International Normalised Ratio of 2 or greater if on warfarin
- Patients who are known to be pregnant are not eligible to participate in this study during the time of the pregnancy
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of patient that agree to undergo 2 biopsy's strictly for research purposes. At 3 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of Michigan
🇺🇸Ann Arbor, Michigan, United States
University of Michigan🇺🇸Ann Arbor, Michigan, United States